| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA838: Slow-release potassium bicarbonate and potassium citrate for treating distal renal tubular acidosis (terminated) |
|
Medicine details |
|
| Medicine name | potassium hydrogen carbonate / potassium citrate (Sibnayal®) |
| Formulation | 8 meq, 24 meq prolonged release granules |
| Reference number | 4276 |
| Indication | Treatment of distal renal tubular acidosis (dRTA) in adults, adolescents and children aged one year and older |
| Company | Advicenne |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 21/06/2021 |
| NICE guidance | |